Clinical Trial Contact Request

EXPANDED ACCESS TO BEZUCLASTINIB TO BE COADMINISTERED WITH SUNITINIB FOR PATIENTS WITH LOCALLY ADVANCED, UNRESECTABLE, OR METASTATIC GASTROINTESTINAL STROMAL TUMORS